Conceptio ›
Archive ›
Gestión del Repositorio Documental de la Universidad de Salamanca
Gestión del Repositorio Documental de la Universidad de Salamancametadata only
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
mieloma múltiple, multiple myeloma, mieloma múltiple
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 296807
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.